18 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
commercialize any products. For example, we may be sued if any product we develop allegedly causes injury or is found to be otherwise unsuitable during product … programs;
injury to our reputation and significant negative media attention;
withdrawal of clinical study participants or cancellation of clinical
8-K
EX-10.1
knfa8tv75rktrqd
27 Jul 23
Index to Financial Statements
5:28pm
DEFM14A
ui2zu5m xuk1hsrlksh
12 May 23
Proxy related to merger
5:00pm
424B3
gtnge8s7 gwlsuh5
12 May 23
Prospectus supplement
4:33pm
S-4
EX-10.11
hvp5brzq4j arsyylprz
23 Dec 22
Registration of securities issued in business combination transactions
6:28pm
S-4
im6j4u9uqw ix
23 Dec 22
Registration of securities issued in business combination transactions
6:28pm
- Prev
- 1
- Next